| Literature DB >> 30320035 |
F Zarei1,2, B Zeinali-Rafsanjani2.
Abstract
RATIONALE ANDEntities:
Keywords: Adherence; Diagnostic Accuracy ; STARD Statement
Year: 2018 PMID: 30320035 PMCID: PMC6169121
Source DB: PubMed Journal: J Biomed Phys Eng ISSN: 2251-7200
Search fields and search terms used in different databases
| Database | Search fields | ||||
|---|---|---|---|---|---|
| Title | Abstract | Keyword/ Mesh | Source title | Topic | |
| Web of Science | Diagnosis OR diagnostic OR accuracy OR sensitivity OR specificity OR efficacy OR Compare | --------- | --------- | ------- | Radiology and nuclear medicine |
| Scopus | Diagnosis OR diagnostic OR accuracy OR sensitivity OR specificity OR efficacy OR Compare | Diagnosis OR diagnostic OR accuracy OR sensitivity OR specificity OR efficacy OR Compare | Diagnosis OR diagnostic OR accuracy OR sensitivity OR specificity OR efficacy OR Compare | Radiology OR imaging OR ultrasound | Radiology and nuclear medicine |
| PubMed | Diagnosis AND diagnostic AND accuracy AND sensitivity AND specificity AND efficacy | --------- | --------- | -------- | |
Figure1Flow chart showing the search results and limitation the results.
The items which were assessed in selected diagnostic accuracy articles to check the adherence of title and abstract section to the STARD. It also assessed if the STARD standard was pointed out in the studies or not.
| STARD | TITLE OR ABSTRACT | ||||
|---|---|---|---|---|---|
| the word "STARD" used in the study | 1a. Title | 1b. Abstract | 2. Structured Abstract | 3. background | 4. study objective |
The items which were assessed in selected diagnostic accuracy articles to check the adherence of method section to the STARD. Item #18 was broken into two sections: 1. If the sample size was pre-specified. 2. How the samples were chosen?
| Method | study design | 5. data collection |
| participants | 6. including/excluding criteria | |
| 7. how eligible participants were identified | ||
| 8. setting, location, and dates | ||
| 9. patient sampling | ||
| Test methods | 10a. Index test, in sufficient detail to allow replication | |
| 10b. reference or gold standard | ||
| 11. Rationale for choosing the reference standard | ||
| 12a. Definition of and rationale for test positivity cut-offs of index test | ||
| 12b. Definition of and rationale for test positivity cut-offs the reference standard | ||
| 13a. clinical information and reference standard results in performers/readers of the index test | ||
| 13b. clinical information and index test results were available to the assessors of the reference standard) | ||
| Analysis | 14. Methods for estimating or comparing measures of diagnostic accuracy | |
| 15. How indeterminate index test or reference standard results were handled | ||
| 16. How missing data on the index test and reference standard were handled | ||
| 17. Any analyses of variability in diagnostic accuracy, distinguishing pre-specified from exploratory | ||
| 18. Intended sample size pre-specified | ||
| How the sample size was chosen |
The items which were assessed in selected diagnostic accuracy articles to check the adherence of result section to the STARD
| Results | Participants | 19. Flow of participants, using a diagram |
| 20. Baseline demographic and clinical characteristics of participants | ||
| 21a. Distribution of severity of disease in those with the target condition | ||
| 21b. Distribution of alternative diagnoses in those without the target condition | ||
| 22. Time interval and any clinical interventions between index test and reference standard | ||
| Test results | 23. Cross tabulation of the index test results (or their distribution) by the results of the reference standard | |
| 24a. Estimates of diagnostic accuracy (accuracy, area under curve or ROC) | ||
| 24b. Estimates of diagnostic accuracy and their precision (such as 95% confidence intervals, SD, Standard error) | ||
| 25. Any adverse events from performing the index test or the reference standard |
The items which were assessed in selected diagnostic accuracy articles to check the adherence of discussion section and other information to the STARD
| DISCUSSION | 26. Study limitations, including sources of potential bias, statistical uncertainty, and generalizability |
| 27. Implications for practice, including the intended use and clinical role of the index test | |
| OTHER INFORMATION | 28. Registration number and name of registry |
| 29. Where the full study protocol can be accessed | |
| 30. Sources of funding and other support; role of funders (conflict of interest) |
The applied keywords for each section of the articles
| Section head | Subsection | Item number | Keywords |
|---|---|---|---|
| TITLE OR ABSTRACT | title or abstract | 1a | “diagnostic accuracy”, “sensitivity and specificity”, “efficacy” |
| 1b | |||
| 2 | |||
| 3 | |||
| 4 | |||
| Method | |||
| study design | 5 | "retrospective", "prospective" | |
| participants | 6 | "include", "exclude" | |
| 7 | "inclusion criteria", "exclusion criteria" | ||
| 9 | "random", Consecutive" | ||
| Test methods | 10b | "gold standard", "reference standard", "standard" | |
| 12a | cut-off | ||
| 12b | cut-off | ||
| 13a | "blind", "mask", "unaware", "knowledge", "observer", "reader" | ||
| 13b | blind, "mask", "unaware", "knowledge", "observer", "reader" | ||
| 14 | "confidence interval" | ||
| 15 | "false", "negative", "positive", "predictive value" | ||
| Analysis | 16 | "miss" | |
| 17 | "subgroup" | ||
| 20 | "years", "male", "female" | ||
| Results | Participants | 21a | "stage", "grade", "level" |
| 21b | "stage", "grade", "level" | ||
| 22 | "interval", "after" | ||
| Test results | 24a | "ROC", "AUC" | |
| 24b | "confidence interval", "standard deviation", "standard error" | ||
| Discussion | 27 | "limitation" |
The characteristics of selected journals in terms of being indexed in different databases (y=yes and n=no), H-index, country
| Journals | Scopus | PUBMED | Web of Science | introduction of STARD in instruction for authors | H-index | Country |
|---|---|---|---|---|---|---|
| Academic Radiology | y | n | y | n | 75 | United States |
| Acta radiologica | y | y | y | n | 57 | United Kingdom |
| American Journal of Neuroradiology | y | y | y | y | 141 | United States |
| American journal of roentgenology | y | y | y | y | 159 | United States |
| Annals of Nuclear Medicine | y | y | y | n | 45 | Japan |
| BMC Medical Imaging | y | y | y | n | 22 | United Kingdom |
| British journal of radiology | y | y | y | n | 86 | United Kingdom |
| Clinical Radiology | y | n | y | y | 71 | United Kingdom |
| Dentomaxillofacial Radiology | n | y | y | n | 54 | United Kingdom |
| Egyptian Journal of Radiology and Nuclear Medicine | y | n | n | n | 4 | Netherlands |
| Emergency Radiology | y | y | y | n | 31 | United States |
| European Journal of Nuclear Medicine and Molecular Imaging | y | n | y | n | 106 | Germany |
| European Journal of Radiology | y | n | y | n | 86 | Ireland |
| European Radiology | y | n | y | n | 118 | Germany |
| IEEE Transactions on Medical Imaging | y | n | y | n | 165 | United States |
| Indian Journal of Radiology and Imaging | y | y | n | n | 14 | India |
| International Journal of Radiation Oncology Biology Physics | y | y | y | n | 198 | United States |
| Investigative radiology | y | y | y | n | 89 | United States |
| JACC: Cardiovascular Imaging | y | y | y | n | 71 | United States |
| Journal of Computer Assisted Tomography | y | y | y | n | 80 | United States |
| Journal of Medical Imaging and Radiation Oncology | y | y | y | y | 30 | Australia |
| Journal of Ultrasound in Medicine | y | y | n | n | 67 | United States |
| Korean Journal of Radiology | y | y | y | y | 38 | South Korea |
| Nuclear Medicine Communication | y | y | y | n | 59 | United States |
| Pediatric Radiology | y | n | y | n | 66 | Germany |
| polish journal of radiology | y | y | n | n | 7 | Poland |
| Practical radiation oncology | y | y | n | n | 13 | Netherlands |
| radiologica medica | y | y | y | n | 34 | Italy |
| Radiology | y | y | y | y | 240 | United States |
| Skeletal Radiology | y | y | y | y | 68 | Germany |
| Ultrasound in Obstetrics and Gynecology | y | y | y | y | 106 | United Kingdom |
| Total | 30 | 23 | 26 | 8 |
The number and percentage of journals which were randomly selected in terms of the country
| Continent | Country | Number/ Country | % | Number/ Continent | % |
|---|---|---|---|---|---|
| America | United States | 12 | 38.71 | 12 | 38.71 |
| Europe | United Kingdom | 6 | 19.35 | 14 | 45.16 |
| Germany | 4 | 12.90 | |||
| Netherlands | 1 | 3.23 | |||
| Italy | 1 | 3.23 | |||
| Ireland | 1 | 3.23 | |||
| Poland | 1 | 3.23 | |||
| Asia | Japan | 1 | 3.23 | 3 | 9.68 |
| Korea | 1 | 3.23 | |||
| India | 1 | 3.23 | |||
| Australia | Australia | 1 | 3.23 | 1 | 3.23 |
| Africa | Egypt | 1 | 3.23 | 1 | 3.23 |
| Total | 31 | 100 | 31 | 100 | |
The number of primarily selected articles and the number of diagnostic accuracy articles
| Journals | Number of selected article | Number of diagnostic accuracy article |
|---|---|---|
| Academic Radiology | 15 | 5 |
| acta radiologica | 6 | 6 |
| American Journal of Neuroradiology | 14 | 12 |
| American journal of roentgenology | 10 | 10 |
| Annals of Nuclear Medicine | 3 | 3 |
| BMC Medical Imaging | 5 | 2 |
| British journal of radiology | 21 | 3 |
| Clinical Radiology | 12 | 5 |
| Dentomaxillofacial Radiology | 9 | 3 |
| Egyptian Journal of Radiology and Nuclear Medicine | 14 | 5 |
| Emergency Radiology | 3 | 1 |
| European Journal of Nuclear Medicine and Molecular Imaging | 9 | 8 |
| European Journal of Radiology | 14 | 14 |
| European Radiology | 8 | 6 |
| IEEE Transactions on Medical Imaging | 3 | 1 |
| Indian Journal of Radiology and Imaging | 10 | 5 |
| International Journal of Radiation Oncology Biology Physics | 11 | 3 |
| Investigative radiology | 16 | 2 |
| JACC: Cardiovascular Imaging | 3 | 3 |
| Journal of Computer Assisted Tomography | 4 | 4 |
| Journal of Medical Imaging and Radiation Oncology | 8 | 7 |
| Journal of Ultrasound in Medicine | 6 | 5 |
| Korean Journal of Radiology | 10 | 2 |
| Nuclear Medicine Communication | 7 | 7 |
| Pediatric Radiology | 5 | 3 |
| polish journal of radiology | 7 | 6 |
| Practical radiation oncology | 7 | 1 |
| radiologica medica | 6 | 3 |
| Radiology | 11 | 8 |
| Skeletal Radiology | 12 | 2 |
| Ultrasound in Obstetrics and Gynecology | 6 | 6 |
| Total | 275 | 151 |
The number and percentage of articles that adhere to different parts of STARD standard
| section | sub group | Items | Number | % | Mean | SD |
|---|---|---|---|---|---|---|
| STARD in text | the word "STARD" used in the study | 1 | 0.66 | ----- | ----- | |
| TITLE OR ABSTRACT | title or abstracts | 1a. Title | 149 | 98.68 | 97.88 | 2.06 |
| 1b. Abstract | 151 | 100 | ||||
| 2. Structured Abstract | 150 | 99.34 | ||||
| 3. background | 145 | 96.03 | ||||
| 4. study objective | 144 | 95.36 | ||||
| Method | study design | 5. data collection | 129 | 85.43 | ----- | ----- |
| participants | 6. including / excluding criteria | 144 | 95.36 | 96.68 | 2.42 | |
| 7. how eligible | 150 | 99.34 | ||||
| 8. location and dates | 142 | 94.04 | ||||
| 9. patient sampling | 148 | 98.01 | ||||
| Test methods | 10a. Index test | 151 | 100 | 77.77 | 13.70 | |
| 10b. reference or gold standard | 133 | 88.08 | ||||
| 11. Reference standard rationality | 127 | 84.11 | ||||
| 12a. test positivity cut-offs of the index test | 116 | 76.82 | ||||
| 12b. test positivity cut-offs the reference standard | 96 | 63.58 | ||||
| 13a. Blind to the index test | 99 | 65.56 | ||||
| 13b. Blind to the reference standard | 100 | 66.23 | ||||
| Analysis | 14. Methods for estimating diagnostic accuracy | 138 | 91.39 | 55.74 | 38.36 | |
| 15. How indeterminate index test or reference standard results were handled | 119 | 78.81 | ||||
| 16. How missing data were handled | 56 | 37.09 | ||||
| 17. Any analyses for distinguishing pre-specified from exploratory | 28 | 18.54 | ||||
| 18a. pre-specified sample size | 16 | 10.6 | ||||
| 18b. How the sample size was chosen | 148 | 98.01 | ||||
| Results | Participants | 19. Flow of participants | 88 | 58.28 | 55.36 | 28.99 |
| 20. Demographics of participants | 146 | 96.69 | ||||
| 21a. Distribution of severity of disease in those with the target condition | 93 | 61.59 | ||||
| 21b. Distribution of alternative diagnoses in those without the target condition | 26 | 17.22 | ||||
| 22. Time interval between index test and reference standard | 65 | 43.05 | ||||
| Test results | 23. Cross tabulation of the index test results | 122 | 80.79 | 66.23 | 38.74 | |
| 24a. Estimates of diagnostic accuracy | 145 | 96.03 | ||||
| 24b. Estimates of precision the diagnostic accuracy | 119 | 78.81 | ||||
| 25. Any adverse events | 14 | 9.27 | ||||
| DISCUSSION | 26. Study limitations | 130 | 86.09 | 93.05 | 9.84 | |
| 27. Implications for practice | 151 | 100 | ||||
| OTHER INFORMATION | 28. Registration number and name of registry | 1 | 0.66 | 35.10 | 36.49 | |
| 29. Where the full study protocol can be accessed | 10 | 6.62 | ||||
| 30. Sources of funding and other support; role of funders | 96 | 63.58 | ||||
| ethics | 105 | 69.54 | ||||
Figure2Up) the score of journals (/100) from each country. Down) the mean score of journals in each continent.